Michael Lehrke

12.3k citations

132 papers · 9.1k indexed · 8 hit papers · h-index 40

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
Endocrine and Autonomic Systems top 1%
- Regulation of Appetite and Obesity

Papers in

Endocrinology, Diabetes and Metabolism 69
- Diabetes Treatment and Management 52
- Diabetes, Cardiovascular Risks, and Lipoproteins 18
Cardiology and Cardiovascular Medicine 41
- Cardiovascular Function and Risk Factors 15

Co-authors: Mitchell A. Lazar Nikolaus Marx Klaus G. Parhofer Uli C. Broedl Daniel J. Rader Muredach P. Reilly Corinna Lebherz Megan L. Wolfe
Journals: European Heart Journal (7 papers)Cardiovascular Diabetology (7 papers)Diabetes (6 papers)Diabetes Obesity and Metabolism (5 papers)Circulation (4 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

Michael Lehrke

121 papers receiving 9.0k citations

Hit Papers

8 papers align trajectories log scale

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes 2022 · 258 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Circulation
2020 Advanced Drug Delivery Reviews
2018 JACC Basic to Translational Science
2008 Molecular Medicine
2005 Circulation
2005 Cell
2005 Diabetes
2000 PubMed

Peers

Countries citing papers authored by Michael Lehrke

Since Specialization

Citations

This map shows the geographic impact of Michael Lehrke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lehrke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lehrke more than expected).

Fields of papers citing papers by Michael Lehrke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lehrke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lehrke. The network helps show where Michael Lehrke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Lehrke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Lehrke Line = papers co-authored together Michael Lehrke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Repeat cardiovascular-related procedures and real-world treatment in high-risk patients with hypercholesterolemia or mixed dyslipidemia Journal of Medical Economics ·Michael Lehrke, S. Mueller, Ulf Maywald, 加藤育民, Uwe Fraass, Anton Sinitsin	2024	0
2	Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial Atherosclerosis ·Jorge Plutzky, Paweł Bogdański, Selçuk Dağdelen, John Deanfield, Scott S. Emerson, G. Kees Hovingh, Steven E. Kahn, Ahmad Salih, Gustavs Latkovskis, Michael Lehrke, Søren Hardt‐Lindberg, Ildiko Lingvay, Stephen C. Nicholls, Tuğçe Kalaycı Oral, G. Nicolini, Sophie Vlaar, Paul M. Ridker, Donna H. Ryan, A. Michael Lincoff	2024	1
3	The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy Circulation Research ·Katharina Schuett, Nikolaus Marx, Michael Lehrke	2023	34
4	Efficacy and Safety of Low-Dose Protamine in Reducing Bleeding Complications during TAVI: A Propensity-Matched Comparison Journal of Clinical Medicine ·Manoshi Sarbendu Bagchi, Michel ERPELDING, Felix Vogt, Klaus K. Witte, Nikolaus Marx, Michael Lehrke, Mohammad Almalla, Jörg Schröder	2023	1
5	GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Circulation ·Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed Sattar Hit paper breakdown →	2022	258
6	SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation Cardiovascular Research ·Luca Liberale, Simon Kraler, Yustina M. Puspitasari, Nicole R. Bonetti, Alexander Akhmedov, Stefano Ministrini, Fabrizio Montecucco, Nikolaus Marx, Michael Lehrke, Minjae Song, Jürg H. Beer, Florian A. Wenzl, Francesco Paneni, Thomas F. Lüscher, Giovanni G. Camici	2022	11
7	The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury Cardiovascular Diabetology ·Florian Kahles, Matthias Rau, Veronica Bankole, Ann Christina Foldenauer, حسین سرکار حسن خان, 张玉玲, Jörg Schröder, Tessel Renzenbrink, Julia Moellmann, Emiel P. C. van der Vorst, Nikolaus Marx, Michael Lehrke	2022	1
8	Serum from Patients with Severe Alcoholic Liver Cirrhosis Inhibits Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells Journal of Clinical Medicine ·Archer Taylor, M Santrůcek, Hamid Reza Rafizadeh, Daniela C. Kroy, Michael Lehrke, и др., Rolf Rossaint, Matthias Barton, Marc Hein	2021	1
9	A systematic review and meta-analysis of murine models of uremic cardiomyopathy Kidney International ·Josefin Soppert, Janina Frisch, Julia J. Wirth, Intan Syafinaz Mohamen Amin Tawakal, Peter Boor, Rafael Kramann, Elmira Khiabani, Julia Moellmann, Michael Lehrke, Mathias Hohl, Emiel P. C. van der Vorst, Christian Werner, Thimoteus Speer, Christoph Maack, Nikolaus Marx, Joachim Jankowski, Letícia Prates Roma, Heidi Noels	2021	23
10	Post-cardiac injury syndrome after transcatheter mitral valve repair using MitraClip system: a case report European Heart Journal - Case Reports ·Libras Asa Saputri, Michael Lehrke, Nikolaus Marx, Mohammad Almalla	2020	9
11	Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction Journal of Clinical Medicine ·Elena Baksheeva, حسین سرکار حسن خان, Florian Kahles, Marcia Viviane Rückbeil, Matthias Rau, Julia Moellmann, Moritz Biener, Mohammad Almalla, Elena Conesa Sánchez, Evangelos Giannitsis, Hugo A. Katus, Nikolaus Marx, Michael Lehrke	2020	7
12	Deep Learning–Based Segmentation and Quantification in Experimental Kidney Histopathology Journal of the American Society of Nephrology ·Nassim Bouteldja, Barbara M. Klinkhammer, Roman D. Bülow, Aileen Foster, Pierre (1589-1637). Auteur du texte Blanchot, Saskia von Stillfried, Julia Moellmann, Susan Sheehan, Ron Korstanje, Sylvia Menzel, Peter Bankhead, Matthias Mietsch, Charis Drummer, Michael Lehrke, Rafael Kramann, Jürgen Floege, Peter Boor, Dorit Merhof	2020	101
13	Empagliflozin improves left ventricular diastolic function of db/db mice Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Julia Moellmann, Barbara M. Klinkhammer, Aileen Foster, Ben A. Kappel, Elena Baksheeva, Sebastian Maxeiner, Anna Artati, Jerzy Adamski, Peter Boor, Katharina Schütt, Gary D. Lopaschuk, Subodh Verma, Nikolaus Marx, Michael Lehrke	2020	45
14	The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation Molecular Metabolism ·Florian Kahles, Ana C. Liberman, V. S. Epifanov, Matthias Rau, Julia Möllmann, حسین سرکار حسن خان, Marcia Viviane Rückbeil, A. J. RELLE, 小池和子, 최병학, Mathias Burgmaier, Corinna Lebherz, Nikolaus Marx, Michael Lehrke	2018	51
15	Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by TargetingMafb Diabetes ·Mengyu Zhu, Yuanyuan Wei, Claudia Geißler, خيرالله فالح وادي الشمري, Agheel Tabar Molla Hassan, Michael Hristov, Julia Möllmann, Michael Lehrke, Ela Karshovska, Andreas Schober	2017	46
16	GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease The American Journal of Medicine ·Corinna Lebherz, Georg Schlieper, Julia Möllmann, Florian Kahles, Marvin I. Schwarz, C Tealdi, Nada Dimković, Alexander Koch, Christian Trautwein, Patti M. Yorks, Nikolaus Marx, Frank Tacke, Michael Lehrke	2017	53
17	Soluble Heparan Sulfate in Serum of Septic Shock Patients Induces Mitochondrial Dysfunction in Murine Cardiomyocytes Shock ·Lukas Märtin, Carsten Peters, Susanne Schmitz, Julia Moellmann, Antons Martincuks, N Heussen, Michael Lehrke, Gerhard Müller‐Newen, Gernot Marx, Tobias Schuerholz	2015	32
18	Arrhythmia causes lipid accumulation and reduced glucose uptake Basic Research in Cardiology ·Matthias Lenski, Quezia Dias de Miranda, Michael Kohlhaas, Austin Kaye Jackson, Oliver Adam, Xiao Yu Tian, Lars Kaestner, Peter Lipp, Michael Lehrke, Christoph Maack, Michael Böhm, Ulrich Laufs	2015	56
19	MMP-1 serum levels predict coronary atherosclerosis in humans Cardiovascular Diabetology ·Michael Lehrke, Martin Greif, Uli C. Broedl, Corinna Lebherz, Rüdiger P. Laubender, Alexander Becker, Franz von Ziegler, Janine Tittus, Maximilian Reiser, Christoph R. Becker, Burkhard Göke, Gerhard Steinbeck, Alexander Leber, Klaus G. Parhofer	2009	62
20	The Many Faces of PPARγ Cell ·Michael Lehrke, Mitchell A. Lazar Hit paper breakdown →	2005	1213

About Michael Lehrke

Michael Lehrke is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Physiology, Surgery and Nephrology, having authored 132 papers that have together received 9.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (52 papers), Metabolism, Diabetes, and Cancer (22 papers), Lipoproteins and Cardiovascular Health (19 papers), Adipokines, Inflammation, and Metabolic Diseases (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Pancreatic function and diabetes (17 papers), Adipose Tissue and Metabolism (16 papers) and Cardiovascular Function and Risk Factors (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Endocrine and Autonomic Systems (657 citations), Physiology (2.5k citations), Epidemiology (3.0k citations) and Cardiology and Cardiovascular Medicine (1.8k citations). Michael Lehrke has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Mitchell A. Lazar, Nikolaus Marx, Klaus G. Parhofer, Uli C. Broedl, Daniel J. Rader, Muredach P. Reilly, Corinna Lebherz, Megan L. Wolfe, Anand Rohatgi and Kitt Falk Petersen. Their work appears in journals such as European Heart Journal, Cardiovascular Diabetology, Diabetes, Diabetes Obesity and Metabolism and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact